DUBLIN (Reuters) – Ireland’s National Immunisation Advisory Committee is expected to recommend that AstraZeneca’s COVID-19 vaccine be restricted for use for people over the age of 60, national broadcaster RTE reported on Monday.
The expert group met to discuss the issue on Monday and RTE said it was due to sign off on the issue shortly. A formal announcement is expected later, it added.
A European Medicines Agency (EMA) investigation of blood clots in the brain reported by some people given the AstraZeneca vaccine has prompted some European countries to change their recommendations on who should be given the vaccine.
(Reporting by Padraic Halpin; editing by David Evans)
